NCT02597712View on ClinicalTrials.gov

YF476 in Barrett's Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 15, 2013

Primary Completion Date

November 28, 2017

Study Completion Date

December 27, 2017

Conditions
Barrett's Esophagus
Interventions
DRUG

YF476

gastrin receptor antagonist

DRUG

YF476 placebo

placebo

Trial Locations (2)

10032

Columbia University, Division of Digestive & Liver Diseases, New York

CB2 0XZ

MRC Cancer Unit, University of Cambridge, Cambridge

All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

University of Cambridge

OTHER

lead

Trio Medicines Ltd.

INDUSTRY

NCT02597712 - YF476 in Barrett's Esophagus | Biotech Hunter | Biotech Hunter